CTOs on the Move

Anrad Corporation

www.anrad.com

 
Anrad Corporation is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.anrad.com
  • 4950 rue Lí©vy
    Saint-Laurent, QC CAN H4R 2P1
  • Phone: 514.856.6920

Executives

Name Title Contact Details

Similar Companies

Quantel Medical

Quantel Medical Inc. is a Bozeman, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tandem Diabetes Care

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump currently on the market; the t:flex® Insulin Pump, the first pump designed for people with greater insulin requirements; and the t:slim G4™ Insulin Pump, the first CGM-enabled pump with touch-screen simplicity. Tandem is based in San Diego, California.

180 Medical Inc

180 Medical Inc is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

First-Call Medical

First-Call Medical is a Billerica, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NOWDiagnostics

NOWDiagnostics Inc., based in Springdale, Ark., is a leader in innovative diagnostics testing. Its ADEXUSDxâ„¢ product line features a lab at your fingertip, using only a single drop of blood to test for a variety of common conditions, illnesses and diseases with results in a matter of minutes. By eliminating the need to send tests to off-site laboratories, NOWDiagnostics has the potential to decrease by days the waiting period to determine test results. The company is currently offering an hCG (pregnancy) test in the United States and Europe, and two cardiac (heart attack) tests and three toxicology tests in Europe. Additional tests are in the development pipeline, including sexually transmitted diseases, more cardiac (heart attack), food intolerances, common infectious diseases and a variety of screening tests.